// App-Quantinova.ai

M4105 2016 AHA : HDAC6 Inhibition Potential in Pulmonary Arterial Hypertension

Researchers

Presenter

  • Olivier Boucherat

Principal Investigators

  • Sophie Chabot

  • Alice Bourgeois

  • Caroline Lambert

  • Sandra Breuils-Bonnet

  • Renee Paradis

  • Steeve Provencher

  • Sebastien Bonnet

  • CRIUCPQ

Medical Centers

  • CHUL, Quebec, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pulmonary arterial hypertension

  • Solid malignancies

Biomarkers

  • Proliferation marker protein Ki-67

  • Histone H2AX

Drug/Treatment

  • Monocrotaline

  • Tubastatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved